Skip to main content
. 2017 Mar 7;19(4):271–278. doi: 10.1016/j.neo.2017.01.008

Figure 3.

Figure 3

Evaluation of NIC in serum according to tumor stage. Samples were pooled according to tumor stage. Data are presented as scatter plots with each cancer type identifiable. Data were compared to healthy controls by one-way ANOVA adjusted for multiple comparisons. ***P < .001, ****P < .0001.